C07K16/34

HLA binding vaccine moieties and uses thereof

The present invention relates to an immunoglobulin derived single-chain fragment variable (scFv) that broadly binds HLA II molecules and uses thereof. In particular, targeting of an antigen to antigen presenting cells with the HLAII-specific targeting unit provided herein find use in enhancing immune responses after vaccination.

Affinity chromatography media for removal of anti-a and/or anti-b antibodies

Embodiments described herein relate to novel chromatography media for removing anti-A and/or anti-B antibodies from a sample, as well as methods of using the same. The media described herein have several advantages over previously described media including, acid and alkaline stability.

Affinity chromatography media for removal of anti-a and/or anti-b antibodies

Embodiments described herein relate to novel chromatography media for removing anti-A and/or anti-B antibodies from a sample, as well as methods of using the same. The media described herein have several advantages over previously described media including, acid and alkaline stability.

SICKLED BETA GLOBIN ANTIBODIES
20260035480 · 2026-02-05 ·

The invention provides anti-.sup.S globin antibodies or antigen binding fragments thereof.

SICKLED BETA GLOBIN ANTIBODIES
20260035480 · 2026-02-05 ·

The invention provides anti-.sup.S globin antibodies or antigen binding fragments thereof.